Skip to main content

Imunon, Inc.

IMNN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0000749647

In the last 90 days, Imunon, Inc. insiders filed 0 open-market purchases and 5 sales; 23 institutions reported holding it in 13F filings for Q2 2026, worth $506.1K in total; no superinvestor holds it.

Q1 2022 vs. Q4 2021

How the institutions holding Imunon, Inc. changed between Q4 2021 and Q1 2022.

All holders in Q1 2022All holders in Q4 2021

13F holders of IMNN: Q4 2021 compared with Q1 2022
MeasureQ4 2021Of which not filed for Q1 2022Q1 2022Change
Holders42124−17
SharesConverted for a 1-for-15 split511.9K12.13525.8K+13.9K (+2.7%)
Value$4.14M$0$2.66M−$1.49M (−35.9%)

1 institution that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (4)

Institutions that held Imunon, Inc. at the end of Q1 2022 but not at the end of Q4 2021.

Institutions new to IMNN in Q1 2022
InstitutionSharesValue% of portfolio
Tower Research Capital LLC (TRC)5,128$26.0K0.00%
Money Concepts Capital Corp331$2.00K0.00%
Royal Bank of Canada2$00.00%
Benjamin F. Edwards & Company, Inc.13$00.00%

Sold out (21)

Institutions that held Imunon, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.

Not filed for Q1 2022 yet (1)

Institutions that held Imunon, Inc. at the end of Q4 2021 and haven't filed a 13F for Q1 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding IMNN in Q4 2021 that haven't filed for Q1 2022
InstitutionShares, Q4 2021Value, Q4 2021
Carroll Financial Associates, Inc.182$0